Announcements Trials
Browse Landscape

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 22Lymphoid 13Breast 9Genitourinary 8Gastrointestinal 8Sarcoma 7Thoracic 6CNS 6Myeloid 5Plasma cell 4Other neoplasm 4Head & Neck 3Dermatologic 3Classical hematology 3Gynecologic 2Other solid neoplasm 1

Conditions

Mesothelioma, Malignant 1

Interventions

Cisplatin 81Gemcitabine 58Carboplatin 57Irinotecan 56Paclitaxel 53Pemetrexed 47Docetaxel 39Nivolumab 33Fluorouracil 30Bevacizumab 27pembrolizumab 25Cyclophosphamide 24Capecitabine 24Oxaliplatin 22Leucovorin 21Topotecan 19durvalumab 17Erlotinib Hydrochloride 17Sorafenib 16Everolimus 16Etoposide 16Bortezomib 16Ipilimumab 15Injections 15atezolizumab 14Sunitinib 14Filgrastim 14Early Intervention, Educational 14alvocidib 13Sirolimus 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Microarray Analysis × Other solid neoplasm × Clear all
NCT00897247 2014-03-05

Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite

Barbara Ann Karmanos Cancer Institute

Completed
494 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡